Abstract:Culture, Immunotherapy, Mesenchymal Stromal Cells (MSCs), Gene Editing, Bioreactor Systems, Regenerative Medicine Cell therapy is revolutionizing modern medicine by offering innovative approaches to treating diseases that were previously considered incurable, such as cancer, organ failure, and degenerative conditions. This editorial summarizes key insights and findings from recent research that explores diverse cell types, innovative induction methods, and advanced culture techniques, all of which drive forward the potential of cell-based therapies. In regenerative medicine, 3D organoid cultures have emerged as a powerful tool for modeling complex tissue structures and functions. The ability to create organoids that mimic human tissues not only improves cell functionality but also provides a valuable platform for disease modeling and drug testing. These advancements in 3D culture techniques are pushing the boundaries of what is possible in cell therapy, offering more realistic models for studying disease mechanisms and developing new therapies (1).Despite the significant progress in cell therapy, several challenges remain. Issues such as off-target effects, the scalability of cell production, and the long-term efficacy of therapies continue to limit their widespread clinical adoption. However, innovations in bioprocessing, gene editing, and culture techniques are steadily addressing these obstacles. The future of cell therapy lies in interdisciplinary collaboration between biologists, engineers, and clinicians. By integrating advanced bioprocessing techniques, optimizing cell delivery methods, and refining immune-modulating therapies, researchers are moving closer to offering accessible, effective, and scalable cellbased treatments. As demonstrated by the research presented in this editorial, the potential for cell therapy to revolutionize healthcare is immense. The next step is ensuring that these therapies reach the patients who need them most.Cell therapy holds transformative potential across a wide range of medical fields, from cancer immunotherapy to regenerative medicine. The integration of innovative cell types, advanced induction methods, and scalable culture techniques is paving the way for the next generation of cell-based therapies. As research in this field continues to evolve, so too does the promise of developing personalized, effective, and safe treatments for a wide array of diseases.

From bacterial operons to gene therapy: 50 years of the journal Cell

CRISPR Gene Therapy: Applications, Limitations, and Implications for the Future

Genome-editing Technologies for Gene and Cell Therapy

Applications of CRISPR technologies to the development of gene and cell therapy

Advances in CRISPR/Cas systems-based cell and gene therapy

Gene and cell therapy of human genetic diseases: Recent advances and future directions

Gene therapy comes of age

Antibiotic-Free Gene Vectors: A 25-Year Journey to Clinical Trials

The once and future gene therapy

Advancing in vivo reprogramming with synthetic biology

In Vivo Cellular Reprogramming: The Next Generation

Cell-free gene expression: an expanded repertoire of applications

Innovations in Molecular Biology-Cutting-Edge Breakthroughs in Molecular Genetics

Engineering transcriptional regulation for cell-based therapies

Role of Recombinant DNA Technology to Improve Life

Current landscape of gene‐editing technology in biomedicine: Applications, advantages, challenges, and perspectives

Addressing the dark matter of gene therapy: technical and ethical barriers to clinical application

Cellular reprogramming by protein degradation: The next frontier in cancer immunotherapy

Therapeutic applications of cell engineering using mRNA technology

The genome editing revolution: review

Editorial: Unlocking the potential of cell therapy: exploring cell types, induction methods, and culture techniques